1D·

My next purchase?!

First, I’d like to officially @Tenbagger2024 officially welcome back from the sidelines! 🫡 It’s great to have you back!

I hope you were able to enjoy your time off, recharge your batteries 🪫, and return with new energy 🔋 and your usual strength 💪. The community has definitely missed a familiar name—without your insights and analyses, things here were almost a little too quiet. 🙇‍♂️

And what can I say: Your comeback came even faster than that of the German national soccer team after their latest setbacks—so the bar wasn’t set too high. 😂⚽

With that in mind: Welcome back, my friend! I’m excited to see which companies you’ll pull out of your sleeve this time and which candidates will once again be scrutinized mercilessly. 💀

————————————————————————-

While the market focuses its attention on the usual suspects, there are always companies that fly largely under the radar. One such candidate has been on my watchlist for quite some time and is now on the verge of making the leap into my portfolio.

Today, I’d like to show you why I consider this company (another stock from Japan) to be an extremely exciting investment candidate.

Today’s focus is on Hoya Corp $7741 (-1.21%)

HOYA Corp.: The Invisible Monopoly of the Optics & Chip World

While the stock market is fixated on $ASML (+1.35%) ASML’s EUV lithography machines or the mass production of wafers by $2330 , a Japanese heavyweight has established itself in the shadow of the tech giants—one without which not a single sub-3nm processor can be manufactured in the age of AI and semiconductors: HOYA Corporation. $7741 (-1.21%)

HOYA $7741 (-1.21%) does not manufacture finished microchips or hospital diagnostic devices. HOYA $7741 (-1.21%) supplies the physically perfect, high-precision materials upon which all global progress in the chip industry and medical technology is built.

The difference from ordinary suppliers is enormous: HOYA $7741 (-1.21%) combines the explosive, high-margin growth of the AI and semiconductor sectors with the crisis resilience of a global medical technology monopoly.

1. The Business Model: The Highly Profitable Dual Engine ⚙️👁️

HOYA $7741 (-1.21%) scales through a perfectly balanced two-pillar model that hedges the cyclical dynamics of the tech world with defensive healthcare cash flows:

① Information Technology (IT) Segment (~46–48% of revenue):

EUV Photomask Blanks: High-purity quartz glass blanks that serve as photomasks for the most advanced chip manufacturers (sub-3nm, high-NA EUV). HOYA $7741 (-1.21%) holds a virtual global monopoly in this sector (>80% market share).
HDD Glass Substrates: Ultra-flat glass substrates for high-capacity hard disk drives in data centers. Glass enables higher storage densities than aluminum—essential for the data deluge generated by AI hyperscalers.
Operating Margin: A staggering ~54.1%! This segment is a true money-making machine that benefits directly from the AI and semiconductor boom.

② Life Care Segment (~52–54% of revenue):

Products: Optometry (eyeglass lenses, contact lenses) and MedTech (PENTAX endoscopes, intraocular lenses for cataracts).
Operating Margin: Extremely solid ~18.1%.
Competitive advantage: Provides a crisis-resistant, non-cyclical foundation. Even if the semiconductor industry stagnates, people will still undergo eye surgeries and purchase vision aids.

2. The Technology: Why Sub-3nm & AI Data Centers Would Fail Without HOYA

HOYA’s unique physical selling point $7741 (-1.21%) lies in its its mastery of glass and materials science at the nanometer scale. Two key drivers make HOYA $7741 (-1.21%) indispensable:

EUV lithography & high-NA EUV: When exposing state-of-the-art chips with extreme ultraviolet (EUV) light, the photomask must be free of any molecular deviations. A tiny defect on the mask can ruin millions of chips. HOYA’s blank materials offer a defect density close to zero. Without HOYA, $7741 (-1.21%) , there would be no yield for $AAPL (-1.16%) Apple Silicon, $NVDA (-1.45%) Nvidia GPUs, or $AMD (+0.37%) AMD processors.

HDD glass substrates for AI data centers: Cloud storage space is growing exponentially. Conventional aluminum platters in hard drives bend under extremely high rotational speeds and multiple layers. HOYA’s specialty glass is stiffer, flatter, and enables significantly higher storage capacities per hard drive.

The Validation Moat: Just as with tooling suppliers, the approval of a new mask blank or glass substrate at TSMC $2330 , Samsung $005930 or Intel $INTC (+6.03%) is a multi-year qualification process. The switching costs for chip manufacturers are immense.

3. Geographic Distribution: Global Players with Little Home Bias 🌍

HOYA $7741 (-1.21%) is listed in Tokyo, but generates just under 85–88% of its revenue abroad. This provides protection against Japan’s domestic demographic trends and yields massive currency advantages when the yen is weak:

REGION :

🇹🇼🇰🇷🇨🇳ASIA/China

Revenue share: ~35%–38%

Key drivers: semiconductor foundries (TSMC, $2330 Samsung $005930 ) IT packaging hubs

🇪🇺Europe

~28%–30%

Strong life care medtech business (eyewear & endoscopes)

🇺🇸North America

~20%–22%

Data center hyperscalers & U.S. chip design (EUV/HDDS)

🇯🇵Japan

~12%–14%

Medtech sales & optical R&D/manufacturing sites

4. Key Financial Metrics (Fundamental Analysis & Financial DNA) 📊

Market Capitalization: ~6.8 to 7.2 trillion JPY (approx. 42–45 billion EUR) – A true global tech/medtech mega-cap on the Tokyo Stock Exchange.
Revenue Growth (Segment Dynamics):
IT segment:
+36% YoY (strongly driven by EUV blanks and AI-driven HDD demand).
Life Care Segment:
+9% YoY (stable, non-cyclical anchor).
Consolidated EBIT margin:
~35–38% – Due to the IT division’s high profit contribution (54.1% margin), the overall performance is on par with the software sector.
Return on Invested Capital (ROIC):
>22% – Indicates excellent opportunities for reinvestment and high capital efficiency.
Free Cash Flow Margin:
>22% – HOYA $7741 (-1.21%) consistently converts operating profits into true FCF.
Balance Sheet Strength: Net debt/EBITDA is negative (net cash). HOYA $7741 (-1.21%) has an extremely large cash reserve and faces absolutely no refinancing risk.

5. Why is this stock exciting? 🚀

The undisputed “hockey stick” segment (EUV boom): As the chip industry switches to high-NA EUV machines from ASML, the demand for even more precise mask blanks is rising dramatically. HOYA $7741 (-1.21%) benefits from every technological leap in the semiconductor industry.

Defensive safety net: If the semiconductor market enters a cyclical correction, the defensive MedTech segment (Life Care) cushions the valuation and ensures rock-solid cash flows.

At the heart of the AI infrastructure hub: HOYA $7741 (-1.21%) benefits twice when it comes to AI: once through the production of logic chips (EUV) and once through the storage of massive amounts of AI data (HDD glass substrates).

6. Risks ⚠️

Geopolitics in East Asia: Since the majority of the IT business is handled by foundries in Taiwan 🇹🇼 and South Korea 🇰🇷, there is a significant concentration risk in the event of a China-Taiwan conflict.
U.S. Export Restrictions: Tighter U.S. sanctions against the Chinese chip industry could dampen shipments of high-end substrates and blanks.
Exchange rate sensitivity (JPY): As a highly export-oriented company (85–88% of revenue from overseas), a sudden appreciation of the yen leads to foreign exchange losses on the balance sheet.

🎯 EARNINGS PREP: What to watch for in the next earnings report?

The upcoming quarterly results (Q1 of fiscal year 2027) from HOYA Corp. are just around the corner:

📅 Date:
Thursday, July 30, 2026 (or July 31, depending on the time zone)

⏱ Time: HOYA typically publishes $7741 (-1.21%) releases its results around 1:30 p.m. JST (approx. 6:30 a.m. German time).

📊 Reporting Period: Just-ended first quarter (3 months ending June 30, 2026).

💡 Analyst expectations (consensus)

Revenue: ~$1.55 to $1.57 billion (driven largely by continued demand in the IT/EUV segment).

Earnings per Share (EPS): ~$1.15

For the upcoming earnings update, the key metrics will primarily focus on the IT division and margin trends. The following points should be on your radar:

1.🎭 EUV & High-NA Blank Volume: Will the strong year-over-year growth in the IT segment (+36%) be confirmed? Pay attention to statements regarding the ramp-up of high-NA EUV photomasks at TSMC and Intel.

2.🏭 HDD Glass Substrate Demand (Hyperscaler Capex): Will call-off volumes for glass substrates continue to rise due to AI data center expansion? This is the second major driver in the IT sector.

3. 🤖Margin Stability in the IT Segment: Can the operating margin in the IT sector hold at the extremely high level of >54% , or will R&D costs for the next sub-2nm generations put pressure on profitability in the short term?

4.🩺 Life Care Stability Check: Will the MedTech segment maintain its steady currency-adjusted growth of ~8–9% YoY with an operating margin of just under ~18%? (Any deviation would indicate weaknesses in the end-consumer market for eyeglass lenses).

5. 💴Yen Effect (FX Tailwinds/Headwinds): To what extent does the exchange rate distort the reported JPY figures compared to organic growth abroad (85–88% of revenue generated overseas)?

My Personal Conclusion & Reaper Rating 🧐

I find that Hoya Corp. $7741 (-1.21%) has been incredibly exciting for quite some time now. To me, the company is the textbook example of a perfect hybrid model: On the one hand, it has a virtually irreplaceable monopoly business that supplies an essential key component for the world’s most advanced semiconductors. On the other hand, the strong, defensive medtech business, with its crisis-proof margins, provides stability that excellently cushions the cyclical fluctuations of the semiconductor sector.

It’s precisely this combination that makes Hoya $7741 (-1.21%) so extraordinary to me. The company combines enormous structural growth with a defensive quality that is extremely rare to find in this form.

Of course, Hoya $7741 (-1.21%) still highly valued, no question about it. However, the stock has already pulled back a bit from its ATH, thereby reducing part of its ambitious valuation. For me, this currently presents an exciting opportunity to gradually build a position in a company that’s been on my watchlist for a long time 👀🙇‍♂️

💀Jack’s Verdict:

Jack’s Take: “If you’re looking for the perfect CRV on the stock market, sooner or later you’ll end up at HOYA. While the masses, in search of the next hype, are chasing after every shovel seller, HOYA holds the monopoly on the specialty glass from which the shovels are forged in the first place.

With the AI and high-NA EUV boom in full swing, the IT division is raking in profits thanks to >54% margin , it’s printing money like a printing press. If the semiconductor cycle stutters briefly, HOYA remains completely unfazed and continues to sell millions of eyeglass lenses, endoscopes, and cataract lenses. You’re not buying a highly speculative tech bet here, but a highly profitable, net-debt-free fortress with a built-in airbag.”

REAPER RATING: 🟢 BUY (Quality Compounder)
REAPER SCORE:
8/10 · Anchor 7–9 (Monopoly-like dual compounder)

@Get_Rich_or_Die_Tryin
@Tenbagger2024
@Raketentoni
@PikaPika0105
@Stocktective
@schlimmschlimm
@Multibagger
@Dividendenopi
@Simpson and, of course, all the others ✌️

15 Comments

Raketentoni@Raketentoni

Hey Brian!

Great post and a top-notch analysis! You’ve definitely unearthed an absolutely fascinating stock that many investors haven’t even noticed on the market.

Since you’re explicitly asking for opinions, here’s my usual dose of straight talk:

I ran your theses through our data scanner and compared them with the raw financial statements.

Here’s the unvarnished feedback—what hits the nail on the head, where you’re looking through rose-colored glasses, and what the numbers really say.

### 👍 Where you’re absolutely spot on (The Praise)

1. **The moat is impressive:** Your description of the business model is spot on. With a market share of over 80% in EUV photomask blanks, Hoya effectively holds a global monopoly on sub-3nm processors. Anyone looking to shape the future of semiconductors (TSMC, Nvidia, Apple) simply can’t get around Hoya.

2. **The dual-engine principle:** The combination of a high-margin tech division (EUV & HDD glass) and a crisis-resistant medtech business (endoscopes, eyeglass lenses) is textbook perfect.

3. **A balance sheet as solid as granite:** Your statement on debt is exactly right. According to our current data, the net debt-to-total-capital ratio stands at **-6.2%**. The company is sitting on a massive cash pile and is completely debt-free on a net basis.

### ⚠️ The Reality Check (Where You’re Wrong / What You’re Overlooking)

As brilliant as the company is from an operational standpoint:
When looking at the valuation and current key metrics, I’m afraid I have to seriously rain on your parade.
You’re brushing off the valuation a bit too casually with *“come back a bit”*.

Here are the hard facts from the engine room:

* **The Valuation Monster (P/E ratio 33.6x):**

Hoya is currently trading at a **P/E ratio of 33.6** and a **price-to-book ratio (P/B) of a whopping 8.3x**.
The group’s overall growth on an LTM basis currently stands at **9.4%**. A P/E ratio of 33 for single-digit to just under double-digit overall growth is incredibly ambitious.
There’s absolutely zero margin for disappointment priced in.

* **Fair value points downward:**

Our data models (12 different financial models) currently indicate a fair value of **$137.49** for the stock.
At a current price of **158.03 USD**, this implies a downside potential of **-13.0%**.

In the quality check, the “Relative Value” score therefore only manages a meager **1.4 out of 5 points** (red zone).

* **Margin slightly overestimated:**

You mention a consolidated EBIT margin of 35–38%. The actual total figure currently stands at a very strong, but slightly lower, **32.4%**.

* **Significant underperformance within the sector:**

Looking at performance over the last 12 months, Hoya has **+20.45%**, but it lags miles behind its direct semiconductor and tech benchmarks (**+92.59%**).

Why?
Because the market clearly sees that, in terms of valuation, the stock is simply stuck at the upper limit.

---

### 🎯 RaketenToni’s Conclusion

Hoya Corp is the prime example of a **top-tier quality company with an outrageously expensive price tag**.

There’s no doubt you’re buying one of the world’s strongest material companies here. But at the current price of about $158, you’re not buying any margin of safety.

**My verdict:**
Anyone who goes all-in on Hoya now, ahead of the July 31 earnings report, is betting that the company will once again shatter the already extremely high expectations in the IT segment.

For the watchlist, this stock gets a solid 10/10.
For a direct purchase, I’d either start with just a tiny initial position or simply wait and see if the earnings release at the end of July triggers a pullback toward the fair value (135–140 USD).

Quality comes at a price—but you don’t have to pay for it at its absolute peak!

•

PikaPika0105@PikaPika0105

I think this company is great, too. Every quality investor should have it in their portfolio!! The valuation has always been a bit high, but they really deliver on that. I also really like the company's strategy.

•

Brian@Aktienhauptmeister

@PikaPika0105 And I think the revenue mix is very well-balanced, too. You don't come across a hybrid company with margins like that every day! And the valuation is fair to slightly overvalued in my opinion 😁

•

PikaPika0105@PikaPika0105

@Aktienhauptmeister Fujifilm $4901 is still available; I actually find it even more appealing.

•

Brian@Aktienhauptmeister

@PikaPika0105 I skimmed through it at some point, but it's been a while 🧐 I'll take a closer look at it in the next few days. What do you think of Asahi Intecc $7747? I think it's super interesting

••

Get_Rich_or_Die_Tryin@Get_Rich_or_Die_Tryin

Great company—I’ve worked with them several times already, and we’ve actually talked about it before. Thanks for the introduction, my friend.🫶🏻 In my opinion, the stock price should drop a bit more before it’s a really good time to buy.😉

•

Brian@Aktienhauptmeister

13H

@Get_Rich_or_Die_Tryin So, under €130 would be pretty tempting for a starter model—let's see if it comes to that 🙇‍♂️

•

Tenbagger2024@Tenbagger2024

Hi, my friend. Thanks for the kind words. Hoya really is a great company, but because of its high PEG, I haven't looked into it in any detail yet.

•

Brian@Aktienhauptmeister

13H

@Tenbagger2024 I hope you stick around for now and don't disappear so suddenly again 🫡 I totally get it—after all, I've had the stock on my watchlist so far, but now might be the chance to get a foot in the door 👀

•

Chris@1Chrischi1

Thanks for the introduction ❤️
What would your entry targets be?

•

Brian@Aktienhauptmeister

@1Chrischi1 I haven't invested yet. I'd like to put in my first tranche somewhere between €125 and €130. What do you think of the company?

•

Chris@1Chrischi1

11H

@Aktienhauptmeister I find it really interesting, if only for the diversification it offers. Japan isn't in my portfolio yet, but I don't see myself making an initial purchase until it reaches €115–120; ideally, I'd wait until it's around €100 at the 52-week low—I've already set my price alerts :)

•

Brian@Aktienhauptmeister

11H

@1Chrischi1 That would definitely be a total gift! I definitely wouldn't hesitate 😁 Let's see how things develop over the next few weeks. And the numbers will be released next week, too 👀

••

Chris@1Chrischi1

@Aktienhauptmeister I saw that; I'm still betting on it 📉

••

Invest2impress@Invest2impress

Thanks for the introduction, my friend. Totally my type! It’s always been a bit on the pricey side, but it’s a high-quality company. Right now, Itochu is the only Japanese stock in my portfolio, so Hoya comes at just the right time 😁 Maybe I’ll buy a batch in the next few days. Thanks!

•